Texting your way to better diabetes control: VA tests customizable support program

NCT ID NCT04227379

Completed Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether a customizable texting program could help veterans with type 2 diabetes improve their blood sugar control. 366 veterans were randomly assigned to receive either standard daily diabetes texts or a more interactive version with check-ins, medication reminders, and optional modules. The goal was to see if the enhanced texting program led to better blood sugar levels over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: texting-based diabetes self-management support program
What this could lead to: If successful, this approach could provide a low-cost, scalable way to help people with diabetes better manage their blood sugar levels.
What could go wrong: This was a behavioral intervention trial, not a drug study. Results may not apply to non-veterans or those without access to texting. The effect on long-term health outcomes is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Jesse Brown VA Medical Center, Chicago, IL

Chicago, Illinois, 60612, United States
North Florida/South Georgia Veterans Health System, Gainesville, FL

Gainesville, Florida, 32608-1135, United States
VA Bedford HealthCare System, Bedford, MA

Bedford, Massachusetts, 01730-1114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.